People living with type 2 diabetes face a 53% higher risk of developing Alzheimer's disease than those without it, according to a new systematic review and meta-analysis published in the journal Alzheimer's Research & Therapy on 9 November 2026. The review, led by researchers from Australia's Curtin University, also estimated how often new Alzheimer's cases actually occur in this group: roughly five for every 1,000 person-years of follow-up.
What the review found
The research team searched four medical databases, MEDLINE, CINAHL, Embase and Scopus, for studies published up to April 2026, according to the paper. From 9,431 articles screened, 40 studies were included, together covering 27,102,559 data points. The authors note that this figure is an unadjusted sum of sample sizes, not a count of unique individuals.
Key results reported in the paper's abstract:
- Pooled incidence: 4.71 Alzheimer's cases per 1,000 person-years among people with type 2 diabetes, drawn from 23 studies.
- Relative risk: an adjusted relative risk of 1.53, or 53% higher risk, drawn from 26 studies.
- Wide variation: the prediction interval for incidence ranged from 0.76 to 29.30 cases per 1,000 person-years, meaning results differed widely between study settings.
- Method matters: studies that identified cases from administrative records found 4.00 cases per 1,000 person-years, while those using other methods of diagnosis found 10.24.
- Women and men: incidence was numerically higher in women (3.62) than in men (2.76) per 1,000 person-years, while the relative risk was similar for both (1.73 and 1.76).
The authors wrote that the findings held up in sensitivity analyses and that statistical tests did not detect significant small-study bias.
Why the researchers focused narrowly
Study author Emmanuel Adewuyi, an investigator fellow at Curtin University's School of Population Health, said earlier reviews had often mixed different types of diabetes or dementia, as reported by The Hindu. This review, he said, focused only on type 2 diabetes and Alzheimer's disease, and estimated how frequently new cases occurred.
"Relative risk tells us how two groups compare, while incidence tells us how often new cases occur," Adewuyi said, according to The Hindu, adding that combining the two gives a clearer picture of the Alzheimer's burden among people with type 2 diabetes.
Why it matters
In their conclusion, the authors said the results support building cognitive risk prevention into routine diabetes care. They argue that presenting both absolute numbers and relative risk extends earlier research, which had mainly emphasised relative risk alone.
The paper's background section notes that epidemiological evidence has long linked type 2 diabetes to a higher risk of dementia, including Alzheimer's disease, but that past syntheses frequently used varied definitions that made the size of the link harder to pin down.
What the findings do not show
A meta-analysis of this kind pools results from observational studies, and the paper reports an association rather than proof that diabetes directly causes Alzheimer's. The wide prediction interval and the gap between diagnostic methods also suggest that the true rate in any given population may differ from the pooled average, according to the figures the authors published.
What next
The authors' recommendation is aimed at health systems: integrating checks on cognitive health into diabetes management. The full paper is available in Alzheimer's Research & Therapy, published by BMC.




